WBC
BLUE

Westpac Banking Corp’s bluebird bio BLUE Stock Holding History

Westpac Banking Corp’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,618
Closed -$4.95M – 808
2018
Q3 		$4.95M Sell
2,618
-1,249
-32% -$2.58M 0.08% 318
2018
Q2 		$7.86M Buy
3,867
+1,159
+43% +$2.64M 0.15% 179
2018
Q1 		$5.99M Buy
2,708
+115
+4% +$293K 0.12% 255
2017
Q4 		$5.98M Buy
2,593
+447
+21% +$907K 0.14% 213
2017
Q3 		$3.82M Buy
2,146
+1,030
+92% +$1.44M 0.08% 316
2017
Q2 		$1.52M Sell
1,116
-633
-36% -$764K 0.03% 445
2017
Q1 		$2.06M Sell
1,749
-633
-27% -$646K 0.02% 554
2016
Q4 		$2.02M Sell
2,382
-235
-9% -$187K 0.02% 483
2016
Q3 		$2.3M Sell
2,617
-201
-7% -$146K 0.02% 446
2016
Q2 		$1.58M Buy
2,818
+919
+48% +$520K 0.02% 536
2016
Q1 		$1.05M Buy
+1,899
New +$1.17M 0.01% 540

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westpac Banking Corp's BLUE Position: Q4 2018 in Review

Westpac Banking Corp sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 2,618 shares — an estimated $4.95M sold.

Westpac Banking Corp first reported a position in BLUE in Q1 2016 and held it in 11 quarters. The position peaked at $7.86M in Q2 2018. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Westpac Banking Corp reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Westpac Banking Corp sold 2,618 bluebird bio shares in Q4 2018, an estimated $4.95M.
  • Westpac Banking Corp first reported a position in bluebird bio in Q1 2016 and held it in 11 quarters.
  • Westpac Banking Corp's bluebird bio position peaked at $7.86M in Q2 2018.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Westpac Banking Corp's 13F filing for Q4 2018, filed 7 Feb 2019.